Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer

余錦秀（2016）。Survival Analysis of Stage IV Non-Small-Cell Lung Cancer of Elderly Patients〔碩士論文，義守大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0074-2806201622433800
Wang, Z., Choi2, S., Lee, J., Huang, Y. S., Chen, F., Zhao, Y., Lin, X., Neuberg, D., Kim, J., & Christiani, D. C. (2015). Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival. Cancer Informatics, (2015-S1), 1-9. https://doi.org/10.4137/CIN.S13976
Grimminger, P. P., Stöhlmacher, J., Vallböhmer, D., Schneider, P. M., Hölscher, A. H., Metzger, R., Danenberg, P. V., & Brabender, J. (2009). Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer. Journal of Oncology, 2009(), 223-227. https://doi.org/10.1155/2009/139590
Kao, H. C., Chang, H. C., Lin, M. C., Fang, W. F., Huang, K. T., Tseng, C. C., Liu, S. F., & Wang, C. C. (2014). Prognostic Value of Chemo-Naïve Serum Carcinoembryonic Antigen Level in Patients with Non-Small-Cell Lung Cancer. 胸腔醫學, 29(4), 200-208. https://www.airitilibrary.com/Article/Detail?DocID=10239855-201408-201407220011-201407220011-200-208
Lu, C. A., Chen, C. H., Wu, Y. C., Liu, H. P., & Tsai, Y. H. (2005). Outcome and Prognostic Factors Associated with Resectable Stage IIIA N2 Non-Small Cell Lung Cancer. 胸腔醫學, 20(6), 541-547. https://doi.org/10.29806/TM.200512.0005